Egyptian Drug Authority (EDA)

The Egyptian Drug Authority (EDA) is Egypt's national authority for medical products, including medical devices and in vitro diagnostics. Within EDA, the Central Administration of Medical Devices handles major device regulatory functions. Manufacturers seeking access to Egypt should distinguish the overall authority, EDA, from the specialized administration and submission platforms used for device transactions.

What does EDA do for medical devices?

EDA evaluates market-entry applications, regulates establishments and imports, monitors device safety and quality, and manages lifecycle controls such as changes, vigilance, and recalls. The Central Administration of Medical Devices also publishes guidance and supports digital services, including the MeDevice platform and activities related to unique device identification.

How are devices classified in Egypt?

Egypt applies risk-based medical device controls, with requirements varying by device class, intended purpose, and technology. The practical route can also depend on whether a product is an IVD, sterile, implantable, software-based, or subject to special controls. A documented classification and pathway assessment should be completed before the dossier is assembled.

Is an Egyptian representative required?

A foreign manufacturer generally needs an authorized local representative and appropriately licensed importing arrangements. The local party supports the application and serves as an important contact for EDA, customs, complaints, vigilance, and corrective actions. Manufacturers should contractually define who controls the registration, how regulatory records are shared, and how changes or a representative transfer will be handled.

What does an EDA medical device submission include?

A typical dossier contains administrative documents, manufacturer and local-party credentials, a device description and intended use, classification, quality-management evidence, market-authorization or reference-country evidence where applicable, labeling, and safety and performance documentation. Higher-risk or novel products can need more extensive clinical, technical, or testing evidence. Portal fields and document authentication requirements should be confirmed before filing.

Does EDA regulate devices after approval?

Yes. Market authorization does not end the regulatory lifecycle. Relevant parties must manage complaints, report incidents and field actions when required, maintain traceability, keep licenses and registrations current, and notify qualifying changes. EDA may publish alerts, perform inspections, or take enforcement action when a device or operator is noncompliant.

How do I contact EDA or find official guidance?

Use the EDA Central Administration of Medical Devices page for official services and updates. EDA lists its call center as 15301 and general email as info@edaegypt.gov.eg; verify the appropriate specialist channel for an active submission.

Related Egypt regulatory topics

See our Egypt medical device registration overview for the practical pathway and local representation considerations.